HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael P Waalkes Selected Research

Arsenic

4/2020KRAS-retroviral fusion transcripts and gene amplification in arsenic-transformed, human prostate CAsE-PE cancer cells.
12/2016Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.
1/2016Arsenic and Environmental Health: State of the Science and Future Research Opportunities.
7/2015Chronic inorganic arsenic exposure in vitro induces a cancer cell phenotype in human peripheral lung epithelial cells.
12/2014Silencing KRAS overexpression in arsenic-transformed prostate epithelial and stem cells partially mitigates malignant phenotype.
11/2014Response to letter to the editor by Cohen et al. (2014) "Re: Waalkes et al.: Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human-relevant doses, Arch Toxicol, 2014".
8/2014Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human-relevant doses.
2/2014Arsenic-induced cancer cell phenotype in human breast epithelia is estrogen receptor-independent but involves aromatase activation.
1/2013Chronic exposure of renal stem cells to inorganic arsenic induces a cancer phenotype.
11/2012The epigenetic effects of a high prenatal folate intake in male mouse fetuses exposed in utero to arsenic.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael P Waalkes Research Topics

Disease

82Neoplasms (Cancer)
04/2020 - 08/2002
52Carcinogenesis
04/2020 - 12/2002
15Hepatocellular Carcinoma (Hepatoma)
03/2012 - 01/2004
9Prostatic Neoplasms (Prostate Cancer)
12/2016 - 12/2002
9Carcinoma (Carcinomatosis)
08/2014 - 05/2004
9Skin Neoplasms (Skin Cancer)
01/2012 - 01/2004
9Arsenic Poisoning
09/2006 - 02/2002
8Lung Neoplasms (Lung Cancer)
07/2015 - 12/2003
8Hyperplasia
03/2012 - 01/2004
7Adenoma (Adenomas)
08/2014 - 11/2004
5Necrosis
06/2013 - 05/2002
5Inflammation (Inflammations)
04/2013 - 07/2004
5Adenocarcinoma of Lung
08/2012 - 09/2006
5Papilloma (Papillomatosis)
05/2010 - 08/2004
4Body Weight (Weight, Body)
11/2012 - 01/2004
3Breast Neoplasms (Breast Cancer)
02/2014 - 05/2005
3Adenocarcinoma
01/2012 - 12/2003
3Liver Neoplasms (Liver Cancer)
10/2011 - 05/2008
3Adrenocortical Adenoma (Disease, Conn's)
05/2010 - 09/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2009 - 09/2008
3Fibrosis (Cirrhosis)
09/2008 - 02/2006
3Liver Cirrhosis (Hepatic Cirrhosis)
03/2008 - 02/2003
3Fibrosarcoma
07/2005 - 01/2004
2Neoplasm Metastasis (Metastasis)
04/2014 - 05/2005
2Cardiovascular Diseases (Cardiovascular Disease)
10/2012 - 03/2005
2Renal Cell Carcinoma (Grawitz Tumor)
03/2012 - 11/2004
1Insulin Resistance
10/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2015
1Hyperglycemia
10/2015
1Leiomyoma (Uterine Fibroids)
04/2015
1Melanoma (Melanoma, Malignant)
01/2015
1Birth Weight (Birth Weights)
08/2014

Drug/Important Bio-Agent (IBA)

69ArsenicIBA
04/2020 - 02/2002
18CarcinogensIBA
01/2017 - 01/2003
16CadmiumIBA
01/2017 - 08/2002
15arseniteIBA
12/2009 - 05/2002
13Drinking WaterIBA
03/2011 - 01/2003
9Proteins (Proteins, Gene)FDA Link
01/2015 - 02/2004
8Arsenicals (Arsenic Compounds)IBA
11/2012 - 08/2004
7DNA (Deoxyribonucleic Acid)IBA
01/2019 - 06/2003
6Estrogens (Estrogen)FDA Link
04/2015 - 03/2004
6MetallothioneinIBA
12/2013 - 07/2004
5sodium arsenite (sodium metaarsenite)IBA
07/2015 - 02/2004
5Matrix Metalloproteinases (MMPs)IBA
02/2014 - 12/2009
5alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2008 - 02/2004
5AndrogensIBA
02/2008 - 10/2004
4MetalsIBA
01/2018 - 07/2004
4Biomarkers (Surrogate Marker)IBA
12/2016 - 10/2007
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2015 - 07/2003
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
09/2012 - 12/2002
4Cyclin D1IBA
09/2011 - 02/2004
4Diethylstilbestrol (Stilbestrol)FDA Link
12/2009 - 02/2006
4EnzymesIBA
09/2009 - 07/2005
3Estrogen ReceptorsIBA
04/2015 - 01/2011
3AgarIBA
01/2013 - 08/2009
3Cacodylic Acid (Cacodylate)IBA
03/2012 - 02/2006
3TamoxifenFDA LinkGeneric
08/2007 - 02/2006
3Keratin-18 (Keratin 18)IBA
10/2006 - 02/2004
3Estrogen Receptor alphaIBA
09/2006 - 02/2006
3O(2)- vinyl- 1- (pyrrolidin- 1- yl)diazen- 1- ium- 1,2- diolateIBA
07/2005 - 08/2003
3NickelIBA
07/2005 - 01/2004
2matrigelIBA
08/2013 - 01/2013
2LeptinIBA
06/2013 - 04/2013
2monomethylarsonic acid (MSMA)IBA
06/2012 - 08/2005
2Fatty Acids (Saturated Fatty Acids)IBA
12/2009 - 03/2005
2Diethylnitrosamine (N-Nitrosodiethylamine)IBA
09/2008 - 02/2007
2Arsenic Trioxide (Trisenox)FDA Link
08/2008 - 08/2004
2Interleukin-6 (Interleukin 6)IBA
03/2008 - 07/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2008 - 10/2006
2Cadmium CompoundsIBA
04/2007 - 10/2004
2Coal (Coals)IBA
09/2006 - 02/2002
2Cisplatin (Platino)FDA LinkGeneric
07/2006 - 06/2004
2Glutathione (Reduced Glutathione)IBA
06/2006 - 06/2004
2TransferasesIBA
06/2006 - 06/2004
2AcetoneIBA
06/2006 - 01/2004
2Complementary DNA (cDNA)IBA
05/2005 - 08/2004
2Phorbol EstersIBA
05/2004 - 01/2004
1Glucose (Dextrose)FDA LinkGeneric
10/2015
1Insulin (Novolin)FDA Link
10/2015
1Triglycerides (Triacylglycerol)IBA
10/2015
1LDL CholesterolIBA
10/2015
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
07/2015
1ATP dependent 26S protease (26S proteasome)IBA
01/2015
1CamptothecinIBA
01/2015
1UbiquitinIBA
01/2015
1PoisonsIBA
01/2015
1Etoposide (VP 16)FDA LinkGeneric
01/2015
1Pharmaceutical PreparationsIBA
01/2015
1Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2015
1Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2015
1trioctyl phosphine oxide (TOPO)IBA
01/2015
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2015
1MicroRNAs (MicroRNA)IBA
04/2014
1Aromatase InhibitorsIBA
02/2014
1monomethylarsonous acidIBA
02/2014
1Aromatase (CYP19)IBA
02/2014
1Endocrine DisruptorsIBA
02/2014
1Letrozole (Femara)FDA LinkGeneric
02/2014

Therapy/Procedure

3Drug Therapy (Chemotherapy)
03/2009 - 06/2003
3Therapeutics
09/2006 - 02/2006